M&A Deal Summary

Strides Pharma Science Acquires Grandix Pharmaceuticals

On June 11, 2007, Strides Pharma Science acquired life science company Grandix Pharmaceuticals for 24M USD

Acquisition Highlights
  • This is Strides Pharma Science’s 1st transaction in the Life Science sector.
  • This is Strides Pharma Science’s largest (disclosed) transaction.
  • This is Strides Pharma Science’s 1st transaction in India.

M&A Deal Summary
Date 2007-06-11
Target Grandix Pharmaceuticals
Sector Life Science
Buyer(s) Strides Pharma Science
Deal Type Add-on Acquisition
Deal Value 24M USD

Target

Grandix Pharmaceuticals

Chennai, India
Grandix Pharmaceuticals, Ltd. is a manufacture of medicines.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Strides Pharma Science

Bangalore, India
Category Company
Founded 1990
Sector Life Science
Employees2,390
Revenue 40.5B INR (2024)
DESCRIPTION

Strides Pharma Science is a pharmaceutical company. Strides operates in pharma generics, branded generics, and biopharma. Strides Pharma Science was founded in 1990 and is based in Bangalore, India.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 1
Country (India) 1 of 1
Year (2007) 1 of 1
Size (of disclosed) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-01-24 Ascent Pharmahealth

Melbourne, Australia

Ascent Pharmahealth Ltd, markets in Australia, Singapore, Malaysia, Hong Kong, Vietnam, Thailand and other Asian countries with a range of generic pharmaceuticals, consumer skincare and over the-counter (OTC) medicines. Ascent has a regional manufacturing facility located in Singapore which manufactures prescription and OTC products in varied dosage forms for the Southeast Asia market.

Sell AU$375M
Mergr

Product

Company

Legal